Voyager Therapeutics, Inc. Contract Liability (Deferred Revenue)
Voyager Therapeutics, Inc. (VYGR) had Contract Liability (Deferred Revenue) of $244.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-08-06
- 2026-06-30: Contract with Customer, Liability, Current $244.00K.
- 2026-03-31: Contract with Customer, Liability, Current $395.00K.
- 2025-12-31: Contract with Customer, Liability, Current $1.59M.
- 2025-09-30: Contract with Customer, Liability, Current $10.58M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2026-06-30 | $244.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $395.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $1.59M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $10.58M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $20.52M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $21.09M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $24.39M 10-K · filed 2026-03-09 |
| 2024-09-30 | $22.63M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $20.52M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $51.44M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $42.88M 10-K · filed 2025-03-11 |
| 2023-09-30 | $44.26M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $31.67M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $5.68M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $59.38M 10-K · filed 2024-02-28 |
| 2022-09-30 | $56.63M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $87.00M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $86.99M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $33.89M 10-K · filed 2023-03-07 |
| 2021-09-30 | $9.54M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $8.07M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $6.44M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $7.73M 10-K · filed 2022-03-08 |
| 2020-09-30 | $13.46M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $43.91M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $46.92M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $47.23M 10-K · filed 2021-02-25 |
| 2019-09-30 | $56.54M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $52.29M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $44.57M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $20.85M 10-K · filed 2020-03-03 |
| 2018-09-30 | $20.25M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $19.84M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $20.22M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $3.38M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |